Sign in

CIK 0001841387 · <br>Emerging growth company

Candel Therapeutics, Inc.

Sign in to watch
Ticker
CADL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522214851
Phone
617-916-5445
Business address
117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Planned sale Chief Executive Officer sold 280,245 shares at an average $11.28 ($3,160,783)
  7. 144 Insider Sale of Securities
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 8-K Event Executive or director change · Regulation FD disclosure
  11. 8-K Event Regulation FD disclosure
  12. 4 Planned sale Chief Technology Officer sold 7,000 shares at $12.00 ($84,000)
  13. 144 Insider Sale of Securities
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Planned sale Chief Scientific Officer sold 23,447 shares at $10.06 ($235,769)
  20. 4 Planned sale Chief Technology Officer sold 7,000 shares at $10.02 ($70,151)

Page 1 of 21 · 418 filings